Collinson, P (2015) Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers. EJIFCC, 26 (3). pp. 183-189. ISSN 1650-3414
SGUL Authors: Collinson, Paul

Preview	PDF Published Version Available under License Creative Commons Attribution Non-commercial. Download (978kB) | Preview
	Microsoft Word (.doc) Accepted Version Available under License Creative Commons Attribution Non-commercial. Download (185kB)

Item Type:	Article
Additional Information:	Copyright © 2015 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords:	biomarkers, cost effectiveness, evidence-based medicine, test evaluation
SGUL Research Institute / Research Centre:	Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Cardiac (INCCCA)
Journal or Publication Title:	EJIFCC
ISSN:	1650-3414
Language:	eng
PubMed ID:	27683493
	Go to PubMed abstract
URI:	https://openaccess.sgul.ac.uk/id/eprint/108964

Actions (login required)

Edit Item